These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10856410)

  • 1. Association between elevated brain natriuretic peptide levels and the development of left ventricular hypertrophy in patients with hypertension.
    Suzuki M; Yamamoto K; Watanabe S; Iwata T; Hamada M; Hiwada K
    Am J Med; 2000 Jun; 108(8):627-33. PubMed ID: 10856410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension.
    Nishikimi T; Yoshihara F; Morimoto A; Ishikawa K; Ishimitsu T; Saito Y; Kangawa K; Matsuo H; Omae T; Matsuoka H
    Hypertension; 1996 Jul; 28(1):22-30. PubMed ID: 8675258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain natriuretic peptide as a risk marker for incident hypertensive cardiovascular events.
    Suzuki M; Hamada M; Yamamoto K; Kazatani Y; Hiwada K
    Hypertens Res; 2002 Sep; 25(5):669-76. PubMed ID: 12452317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
    Kohno M; Yokokawa K; Minami M; Kano H; Yasunari K; Hanehira T; Yoshikawa J
    Am J Med; 1999 May; 106(5):544-9. PubMed ID: 10335726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible correlation among echocardiographic measures, serum brain natriuretic peptide, and angiotensin II levels in hypertensive kidney transplanted children.
    Gheissari A; Sabri M; Pirpiran M; Merrikhi A
    Exp Clin Transplant; 2013 Apr; 11(2):128-33. PubMed ID: 23477424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arterial hypertension, echocardiographically determined left ventricular hypertrophy and N-terminal pro-B type natriuretic peptide levels in women population aged 56-65 years].
    Shipilova T; Pshenichnikov I; Anier A; Borodin A; Riipulk E; Karaĭ D; Meĭgas K; Kaĭk Iu
    Kardiologiia; 2009; 49(7-8):56-61. PubMed ID: 19656109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The limited value of plasma B-type natriuretic peptide for screening for left ventricular hypertrophy among hypertensive patients.
    Nakamura M; Tanaka F; Yonezawa S; Satou K; Nagano M; Hiramori K
    Am J Hypertens; 2003 Dec; 16(12):1025-9. PubMed ID: 14643576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased plasma concentrations of N-terminal pro-brain natriuretic peptide reflect the presence of mildly reduced left ventricular diastolic function in hypertension.
    Furumoto T; Fujii S; Mikami T; Inoue M; Nishihara K; Kaga S; Imagawa S; Goto K; Komuro K; Yamada S; Onozuka H; Kitabatake A; Sobel BE
    Coron Artery Dis; 2006 Feb; 17(1):45-50. PubMed ID: 16374141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients.
    Wei T; Zeng C; Chen L; Chen Q; Zhao R; Lu G; Lu C; Wang L
    Eur J Heart Fail; 2005 Jan; 7(1):75-9. PubMed ID: 15642535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Index of Maladaptive Myocardial Remodeling in Hypertension.
    Goh VJ; Le TT; Bryant J; Wong JI; Su B; Lee CH; Pua CJ; Sim CPY; Ang B; Aw TC; Cook SA; Chin CWL
    Circ Cardiovasc Imaging; 2017 Sep; 10(9):e006840. PubMed ID: 28847911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D; Matias JS; Sargento L; Cabral MJ; Madeira HC
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor.
    Kohno M; Horio T; Yokokawa K; Yasunari K; Ikeda M; Minami M; Kurihara N; Takeda T
    Am J Med; 1995 Mar; 98(3):257-65. PubMed ID: 7872342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension.
    Muscholl MW; Schunkert H; Muders F; Elsner D; Kuch B; Hense HW; Riegger GA
    Am Heart J; 1998 Jan; 135(1):58-66. PubMed ID: 9453522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
    Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
    Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of natriuretic peptides in diagnosis of left ventricular hypertrophy in obese hypertensive patients with metabolic syndrome].
    Spác J; Beránek M; Němcová H; Kianička B; Souček M
    Vnitr Lek; 2013 Sep; 59(9):769-75. PubMed ID: 24073948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interplay between haemodynamic load, brain natriuretic peptide and left atrial size in the early stages of essential hypertension.
    Tsioufis C; Stougiannos P; Taxiarchou E; Skiadas I; Chatzis D; Thomopoulos C; Lalos S; Stefanadis C; Kallikazaros I
    J Hypertens; 2006 May; 24(5):965-72. PubMed ID: 16612260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An increased B-type natriuretic peptide in the absence of a cardiac abnormality identifies those whose left ventricular mass will increase over time.
    Nadir MA; Gandy S; Ireland S; MacDonald T; Dow E; Houston G; Lang C; Struthers A
    JACC Heart Fail; 2015 Jan; 3(1):87-93. PubMed ID: 25454393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial and brain natriuretic peptide and endothelin-1 concentration in patients with idiopathic arterial hypertension: the dependence on the selected morphological parameters.
    Irzmański R; Banach M; Piechota M; Kowalski J; Barylski M; Cierniewski C; Pawlicki L
    Clin Exp Hypertens; 2007 Apr; 29(3):149-64. PubMed ID: 17497342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum B-type natriuretic peptide does not increase with higher systolic blood pressure in obese men despite evidence of blood pressure-related increases in left ventricular mass and filling pressure.
    Asferg CL; Andersen UB; Linneberg A; Hedley PL; Christiansen M; Goetze JP; Jeppesen JL
    Peptides; 2020 Dec; 134():170390. PubMed ID: 32882353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.